Acadia Pharmaceuticals buy Deutsche Bank Aktiengesellschaft
Start price
21.05.25
/
50%
€19.69
Target price
21.05.26
€30.98
Performance (%)
-3.28%
Price
25.03.26
€19.04
Summary
This prediction is currently active. With a performance of -3.28%, the BUY prediction by Deutsche_Bank_Aktien is trending in the wrong direction. This prediction currently runs until 21.05.26. The prediction end date can be changed by Deutsche_Bank_Aktien at any time. Deutsche_Bank_Aktien has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 7.540% | 7.540% |
| iShares Core DAX® | -1.034% | -9.171% |
| iShares Nasdaq 100 | -1.947% | -2.616% |
| iShares Nikkei 225® | -0.425% | -9.424% |
| iShares S&P 500 | -1.201% | -2.986% |
Comments by Deutsche_Bank_Aktien for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft to $35.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat